季度财报
NewAmsterdam Pharma(NAMS)
$NewAmsterdam Pharma(NAMS)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-25-103521 Act: 34 Size: 8 MB 网页链接
$NewAmsterdam Pharma(NAMS)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-25-103521 Act: 34 Size: 8 MB 网页链接